A new study identifies beta frequency neural activity in the anterior cingulate cortex (ACC) as crucial for recognizing rewards and shaping behavior. This neural signature is altered in patients with depression, suggesting it could serve as a biomarker and potential treatment target for anhedonia.
A new study identifies beta frequency neural activity in the anterior cingulate cortex (ACC) as crucial for recognizing rewards and shaping behavior. This neural signature is altered in patients with depression, suggesting it could serve as a biomarker and potential treatment target for anhedonia.
Share this Article
Recommended